fr   en
Clinical Studies
Phase :    
Announcement :   
Select a Pharma :
Select a product :
Select a disease :
Choose date:
[<<]      «      42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52      »      [57]
Date Phase Anouncement Biotech Pharma Product Disease Country Other
2007-09-05 II Result Antisoma (UK)   ASA404 non-small cell lung cancer   See details
2007-09-05 II Result Evotec (Germany)   EVT 201 (partial positive allosteric modulator of the GABAa receptor complex) primary insomnia USA See details
2007-09-02 II Result Actelion (Switzerland)   almorexant primary insomnia Europe and Israel See details
2007-08-30 III Result Pharming (The Netherlands)   Rhucin® hereditary angieodema   See details
2007-08-29 I Launch Orexo (Sweden)   OX19 (sublingual desmopressin) urinary incontinence Sweden See details
2007-08-28 I-II Launch TopoTarget (Denmark) Curagen (USA)   belinostat (PXD101 - histone deacetylase inhibitor) acute myeloid leukemia EU (Germany, France, UK) See details
2007-08-28 I Launch ExonHit Therapeutics (France) Allergan (USA) EHT/AGB001 pain EU See details
2007-08-22 III Result Newron (Italy) Merck Serono (Germany) safinamide Parkinson's disease   See details
2007-08-06 II Launch GTC Biotherapeutics (USA) LEO Pharma (Denmark) Atryn® (recombinant antithrombin) disseminated intravascular coagulation (DIC) in association with severe sepsis EU See details
2007-08-06 II Launch Antisoma (UK)   AS1411 acute myeloid leukemia USA See details
2007-08-02 II Result Oxford Biomedica (UK) Sanofi-Aventis (France) Trovax® (therapeutic vaccine - attenuated version of vaccinia virus modified to deliver the gene for the 5T4 tumour antigen ) colorectal cancer   See details
2007-08-02 II Launch Kuros Biosurgery (Switzerland)   PDGF-fibrin combination severe burns EU See details
2007-07-30 I Launch Neurosearch (Denmark) Abbott (USA) ABT-560 (neuronal nicotinic receptor modulator) CNS disorders   See details
2007-07-26 II Launch Clavis Pharma (Norway)   Elacyt® malignant melanoma USA and Europe See details
2007-07-26 IIa Result OctoPlus (Netherlands) Biolex Therapeutics (USA)   Locteron® (controlled realease interferon alfa) chronic hepatitis C   See details
[<<]      «      42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52      »      [57]